Elite Pharmaceuticals Announces Q1 FY2027 Results Conference Call (Aug 14, 2026)

What Happened

• Elite Pharmaceuticals, Inc. filed an 8-K (furnished) on August 11, 2026, attaching a press release dated August 10, 2026, announcing it will host a conference call to discuss its first quarter fiscal 2027 results for the quarter ended June 30, 2026. The conference call is scheduled for August 14, 2026 at 11:30 AM EDT. The 8-K does not include the company’s financial figures—only the announcement and call logistics.

Key Details

• Press release date: August 10, 2026; 8-K furnished: August 11, 2026; quarter ended: June 30, 2026.
• Conference call: August 14, 2026 at 11:30 AM EDT. Dial-ins: domestic 1-800-346-7359; international 1-973-528-0008; conference number 98840.
• Question submission: email dianne@elitepharma.com — general questions by 5:00 PM EDT on Wednesday, August 12, 2026; financial questions by 7:00 PM EDT on Friday, August 13, 2026.
• Exhibit: Press release attached as Exhibit 99.1 (furnished under Regulation FD). The filing states the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless explicitly stated.

Why It Matters

• Investors should note the company has set the date and logistics for discussing its quarterly earnings (earnings, revenue, and other quarterly results) but did not disclose financial results in this 8-K. Shareholders and analysts who want the company’s actual results or to ask financial questions should submit questions by the stated deadlines and join the call on Aug 14, 2026.
• Because the press release was furnished under Regulation FD and not “filed,” it limits certain legal liabilities and means the content may not be automatically incorporated into other SEC filings.